These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26342332)

  • 1. Validity of self-report of lipid medication use: the Atherosclerosis Risk in Communities (ARIC) Study.
    Bhaskara S; Whitsel EA; Ballantyne CM; Folsom AR
    Atherosclerosis; 2015 Oct; 242(2):625-9. PubMed ID: 26342332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity and reliability of self-reported diabetes in the Atherosclerosis Risk in Communities Study.
    Schneider AL; Pankow JS; Heiss G; Selvin E
    Am J Epidemiol; 2012 Oct; 176(8):738-43. PubMed ID: 23013620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity of Self-Reported Medication Use Compared With Pharmacy Records in a Cohort of Older Women: Findings From the Women's Health Initiative.
    Drieling RL; LaCroix AZ; Beresford SA; Boudreau DM; Kooperberg C; Heckbert SR
    Am J Epidemiol; 2016 Aug; 184(3):233-8. PubMed ID: 27402774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using imputed pre-treatment cholesterol in a propensity score model to reduce confounding by indication: results from the multi-ethnic study of atherosclerosis.
    Jorgensen NW; Sibley CT; McClelland RL
    BMC Med Res Methodol; 2013 Jun; 13():81. PubMed ID: 23800038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eligibility for statin therapy according to new cholesterol guidelines and prevalent use of medication to lower lipid levels in an older US Cohort: the Atherosclerosis Risk in Communities Study Cohort.
    Miedema MD; Lopez FL; Blaha MJ; Virani SS; Coresh J; Ballantyne CM; Folsom AR
    JAMA Intern Med; 2015 Jan; 175(1):138-40. PubMed ID: 25401375
    [No Abstract]   [Full Text] [Related]  

  • 6. A Comparison of Self-reported Medication Adherence to Concordance Between Part D Claims and Medication Possession.
    Savitz ST; Stearns SC; Zhou L; Thudium E; Alburikan KA; Tran R; Rodgers JE
    Med Care; 2017 May; 55(5):500-505. PubMed ID: 28221276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of Self-Reported Heart Failure. The Atherosclerosis Risk in Communities (ARIC) Study.
    Camplain R; Kucharska-Newton A; Loehr L; Keyserling TC; Layton JB; Wruck L; Folsom AR; Bertoni AG; Heiss G
    J Card Fail; 2017 Nov; 23(11):802-808. PubMed ID: 28893677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary artery calcium in relation to initiation and continuation of cardiovascular preventive medications: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Nasir K; McClelland RL; Blumenthal RS; Goff DC; Hoffmann U; Psaty BM; Greenland P; Kronmal RA; Budoff MJ
    Circ Cardiovasc Qual Outcomes; 2010 May; 3(3):228-35. PubMed ID: 20371760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts.
    McAdams MA; Maynard JW; Baer AN; Köttgen A; Clipp S; Coresh J; Gelber AC
    J Rheumatol; 2011 Jan; 38(1):135-41. PubMed ID: 21123328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of self-reported osteoporosis in mid-age and older women.
    Peeters GM; Tett SE; Dobson AJ; Mishra GD
    Osteoporos Int; 2013 Mar; 24(3):917-27. PubMed ID: 22673826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: the atherosclerosis risk in communities study.
    Lopez FL; Agarwal SK; Maclehose RF; Soliman EZ; Sharrett AR; Huxley RR; Konety S; Ballantyne CM; Alonso A
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):155-62. PubMed ID: 22227953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
    Nasir K; Bittencourt MS; Blaha MJ; Blankstein R; Agatson AS; Rivera JJ; Miedema MD; Sibley CT; Shaw LJ; Blumenthal RS; Budoff MJ; Krumholz HM
    J Am Coll Cardiol; 2015 Oct; 66(15):1657-68. PubMed ID: 26449135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric Properties of the Four-Item Morisky Green Levine Medication Adherence Scale among Atherosclerosis Risk in Communities (ARIC) Study Participants.
    Beyhaghi H; Reeve BB; Rodgers JE; Stearns SC
    Value Health; 2016 Dec; 19(8):996-1001. PubMed ID: 27987650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis.
    Ramcharan AS; Van Stralen KJ; Snoep JD; Mantel-Teeuwisse AK; Rosendaal FR; Doggen CJ
    J Thromb Haemost; 2009 Apr; 7(4):514-20. PubMed ID: 19036068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Medications With Lower Odds of Typical COVID-19 Symptoms: Cross-Sectional Symptom Surveillance Study.
    Urbach D; Awiszus F; Leiß S; Venton T; Specht AV; Apfelbacher C
    JMIR Public Health Surveill; 2020 Dec; 6(4):e22521. PubMed ID: 33197879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common Medications and Intracerebral Hemorrhage: The ARIC Study.
    Sharma R; Matsushita K; Wu A; Jack CR; Griswold M; Mosley TH; Fornage M; Gottesman RF
    J Am Heart Assoc; 2021 Feb; 10(5):e014270. PubMed ID: 33586464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Lipid Monitoring on Treatment Intensification of Cholesterol Lowering Therapies (from the Veterans Affairs Healthcare System).
    Jia X; Ramsey DJ; Rifai MA; Ahmed ST; Akeroyd JM; Dixon DL; Gluckman TJ; Nambi V; Ballantyne CM; Petersen LA; Stone NJ; Virani SS
    Am J Cardiol; 2020 Mar; 125(6):874-879. PubMed ID: 31952841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Flueckiger P; Qureshi W; Michos ED; Blaha M; Burke G; Sandfort V; Herrington D; Yeboah J
    Clin Cardiol; 2017 Mar; 40(3):163-169. PubMed ID: 27859433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.